 |
|
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Takuma Nakatsuka, Ryosuke Tateishi
Clin Mol Hepatol. 2023;29(1):51-64. Published online 2022 Jul 29 DOI: https://doi.org/10.3350/cmh.2022.0095
|
|
Citations to this article as recorded by
 Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
Ruolin Zhao, Caiyun Zhang, Chenchen Tang, Xinxin Wu, Sheng Hu, Qingqiong Luo, Ning Jia, Lingzhi Fan, Yixing Wang, Wencheng Jiang, Qilong Chen
Journal of Ethnopharmacology.2025; 336: 118706. CrossRef A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
Journal of Hepatology.2025; 82(2): 235. CrossRef Ashwagandharishta compounds possess affinity interactions against diabetes-linked liver cancer: Implications from network pharmacology, molecular docking and dynamics simulations
Annadurai Vinothkanna, Ligang Chen, Ragothaman Prathiviraj, Srinivasan Prabhu, Rekha Thiruvengadam, Thasma Raman Sivakumar
South African Journal of Botany.2025; 177: 26. CrossRef The prognosis of patients with co-morbid diabetes and hepatitis B and strategies for improving outcome
Xiyu Liu, Xiaohong Wang
The American Journal of the Medical Sciences.2025; 369(5): 638. CrossRef AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
Journal of Hepatology.2025; 82(6): 1080. CrossRef Serum proteomic and metabolomic profiling of hepatocellular carcinoma patients co-infected with Clonorchis sinensis
Zeli Tang, Caibiao Wei, Xueling Deng, Qiumei Lin, Qiping Hu, Shitao Li, Jilong Wang, Yuhong Wu, Dengyu Liu, Min Fang, Tingzheng Zhan
Frontiers in Immunology.2025;[Epub] CrossRef Effect of metformin on hepatocellular carcinoma patients with type II diabetes receiving transarterial chemoembolization: a multicenter retrospective cohort study
Lei Chen, Linxia Wu, Lijie Zhang, Bo Sun, Wenlong Wu, Yu Lei, Licheng Zhu, Tao Sun, Bin Liang, Huangxuan Zhao, Chuansheng Zheng
International Journal of Surgery.2025; 111(1): 828. CrossRef A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
Linxia Wu, Lei Chen, Lijie Zhang, Yiming Liu, Die Ouyang, Wenlong Wu, Yu Lei, Ping Han, Huangxuan Zhao, Chuansheng Zheng
Journal of Hepatocellular Carcinoma.2025; Volume 12: 77. CrossRef Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after vira
Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
Clinical and Molecular Hepatology.2025; 31(1): e64. CrossRef Impact of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease on Hepatocellular Carcinoma Incidence and Long-Term Prognosis Post-Liver Resection: A Systematic Review and Meta-Analysis
Qingyan Kong, Diao Kong, Bei Li, Wei Peng, Zheyu Chen
Academic Radiology.2025;[Epub] CrossRef Predicting the early therapeutic response to hepatic artery infusion chemotherapy in patients with unresectable HCC using a contrast-enhanced computed tomography-based habitat radiomics model: a multi-center retrospective study
Mingsong Wu, Zenglong Que, Shujie Lai, Guanhui Li, Jie Long, Yuqin He, Shunan Wang, Hao Wu, Nan You, Xiang Lan, Liangzhi Wen
Cellular Oncology.2025;[Epub] CrossRef Non-liver comorbidity in patients with hepatocellular carcinoma and curative treatments – a Swedish national registry study
Malin Sternby Eilard, Madeleine Helmersson, Magnus Rizell, Juan Vaz, Fredrik Åberg, Helena Taflin
Scandinavian Journal of Gastroenterology.2025; : 1. CrossRef Non-receptor Type PTPases and their Role in Controlling Pathways Related to Diabetes and Liver Cancer Signalling
Nidhee Chaudhary, Bellam Kiranmayee
Current Pharmaceutical Biotechnology.2025; 26(5): 654. CrossRef Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms
Ya. V. Dvoryanchikov, S. M. Deunezhewa, I. A. Yatskov, V. A. Beloglazov
Problems of Endocrinology.2025; 71(2): 75. CrossRef The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review
Shang‐Chin Huang, Jia‐Horng Kao
The Kaohsiung Journal of Medical Sciences.2024; 40(1): 6. CrossRef Exploring the links between types 2 diabetes and liver‐related complications: A comprehensive review
Lukas Otero Sanchez, Yuping Chen, Guillaume Lassailly, Xiaolong Qi
United European Gastroenterology Journal.2024; 12(2): 240. CrossRef The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma
Yuhua Mai, Liheng Meng, Ganlu Deng, Yingfen Qin
Journal of Hepatocellular Carcinoma.2024; Volume 11: 159. CrossRef Hepatic Stellate Cell‐Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis
Lei Wang, Jieying Zhou, Jian Wang, Xiaotang Wang, Haijuan Dong, Lingzhi Zhao, Junchen Wu, Juanjuan Peng
Advanced Healthcare Materials.2024;[Epub] CrossRef Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies
Alhussain Yasin, Madison Nguyen, Angad Sidhu, Priyanka Majety, Jared Spitz, Amon Asgharpour, Mohammad S. Siddiqui, Laurence S. Sperling, Arshed A. Quyyumi, Anurag Mehta
Diabetes Research and Clinical Practice.2024; 211: 111650. CrossRef SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea
Hyo Jung Cho, Eunyoung Lee, Soon Sun Kim, Jae Youn Cheong
Scientific Reports.2024;[Epub] CrossRef MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy
Xianjun Yu, Mengyuan Feng, Jian Guo, Haoyu Wang, Jun Yu, Anjie Zhang, Jingyi Wu, Yamei Han, Zequn Sun, Yingying Liao, Qun Zhao
Cell Death & Differentiation.2024; 31(8): 1085. CrossRef Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping Review
Elsa Vitale, Alessandro Rizzo, Kazuki Santa, Emilio Jirillo
Biology.2024; 13(5): 352. CrossRef The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Iida Tuunanen, Ari Hautakoski, Heikki Huhtamäki, Martti Arffman, Reijo Sund, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Elina Urpilainen
Biomedicines.2024; 12(8): 1654. CrossRef Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
Clinical and Molecular Hepatology.2024; 30(3): 326. CrossRef Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment
Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn
Cancers.2024; 16(15): 2652. CrossRef Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
Clinical and Molecular Hepatology.2024; 30(4): 1039. CrossRef A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease
Alina-Veronica Ghionescu, Andrei Sorop, Ekaterini Linioudaki, Cristin Coman, Lorand Savu, Marton Fogarasi, Daniela Lixandru, Simona Olimpia Dima
Scientific Reports.2024;[Epub] CrossRef Diabetes Mellitus Negatively Impacts Outcomes of HBV-Related Hepatocellular Carcinoma Following Thermal Ablation
Kuo-Cheng Wu, I-Cheng Lee, Chien-An Liu, Nai-Chi Chiu, Shao-Jung Hsu, Pei-Chang Lee, Chi-Jung Wu, Chen‐Ta Chi, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang
Journal of Hepatocellular Carcinoma.2024; Volume 11: 2257. CrossRef Evolution of characteristics of MASLD with and without diabetes: a meta-analysis of placebo arms
Han Ah Lee, Hye Ah Lee, Hwi Young Kim
Scientific Reports.2024;[Epub] CrossRef The Influence of Sex and Age on Survival in Patients with Hepatocellular Carcinoma
Iuliana Pompilia Radu, Bernhard Scheiner, Jonas Schropp, Maria Gabriela Delgado, Birgit Schwacha-Eipper, Chaonan Jin, Jean-Francois Dufour, Matthias Pinter
Cancers.2024; 16(23): 4023. CrossRef All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease
Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Shih-Jer Hsu, Chun-Ming Hong, Ting-Yuan Lan, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Jia-Horng Kao
Journal of Hepatology.2024;[Epub] CrossRef The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(1): 99. CrossRef The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study
Eun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, Yuri Cho, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Su Jong Yu
PLOS Medicine.2023; 20(6): e1004244. CrossRef Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Takao Watanabe, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka, Norio Horiike, Yoshinori Tanaka, Atsushi Hiraoka, Fujimasa Tada, Hironori Ochi, Yoshiyasu Kisaka, Seiji Nakanishi, Sen Yagi, Kazuhiko Yamauchi, Makoto Higashino, Kana Hirooka, Makoto Morita, Y
Scientific Reports.2023;[Epub] CrossRef Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
Mona Mohamed Ibrahim Abdalla
World Journal of Gastroenterology.2023; 29(27): 4271. CrossRef Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography
Madalina-Gabriela Taru, Monica Lupsor-Platon
Cancers.2023; 15(16): 4097. CrossRef To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases
Wen-Ling Lee, Peng-Hui Wang, Szu-Ting Yang, Chia-Hao Liu, Wen-Hsun Chang, Fa-Kung Lee
Journal of the Chinese Medical Association.2022; 85(12): 1109. CrossRef
|